Mice treated with Fads2 siRNA exhibited markedly aggravated IMQ‐induced skin inflammation, as evidenced by increased ear thickness, elevated PASI scores, pronounced epidermal hyperplasia, and enhanced dermal inflammatory cell infiltration (Figure 2B–F). This evidence concerns the gene FADS2 and dermatitis.